A meta-analysis published in JAMA Dermatology confirmed which hidradenitis suppurativa treatments elicit the best ...

Shares of HDFC Life Insurance, HDB Financial, ICICI Lombard, Just Dial will remain in focus as companies will declare Q1 ...

Sun Pharma shares surged after a settlement with Incyte over Leqselvi, a drug for severe hair loss. The agreement includes a ...

Nifty briefly jumped past the 25,200 mark on the back of broad-based buying, with broader markets outperforming as midcaps ...

Indian drugmaker Sun Pharmaceutical Industries together with its subsidiaries announced that further to its intimation dated ...

LEQSELVI has been approved by the US FDA, following strong results from clinical trials and is now available to adults ...

India VIX, the fear gauge, eased 3 percent which suggests that there are little-to-no signs of panic-driven exits.

Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval ...

Good morning!The GIFT Nifty was up 15 points at 25,167 as of 6:40 a.m., indicating a flat start for the benchmark Nifty 50. Asian equities followed the US in posting modest gains even as trade ...

In a regulatory filing on Monday, Sun Pharma announced that it has reached a settlement and licensing agreement with Incyte ...

Indian equity indices, Sensex and Nifty, are expected to open on flat-to-higher note on Tuesday following positive global ...